-
Mashup Score: 0PSA density is complementary to prostate MP-MRI PI-RADS scoring system for risk stratification of clinically significant prostate cancer - 2 year(s) ago
While prostate multiparametric-magnetic resonance imaging (MP-MRI) has improved the diagnosis of clinically significant prostate cancer (CSPC), the complementary use of prostate-specific antigen (PSA) levels to risk-stratify for CSPC requires further study. The objective of this project was to determine if prostate MP-MRI and PSA can provide complementary insights into CSPC risk stratification….
Source: www.nature.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 4Dr. Siddiqui on first-line treatments for bladder cancer - 3 year(s) ago
“This category of therapeutic is fairly well-tolerated; safe to give,” says Mohummad M. Siddiqui MD.
Source: Urology TimesCategories: Latest Headlines, UrologyTweet-
Dr. Siddiqui on first-line treatments for bladder cancer https://t.co/mMrtNPyIuu #urology #urologist #bladdercancer @MMSiddiquiMD @UMMC
-
-
Mashup Score: 0
“Some of the discussion going on right now is how to improve the morbidity of bladder cancer treatment by pursuing such things…as bladder sparing approaches when feasible…and so, I think that’s very exciting,” says Mohummad M. Siddiqui MD.
Source: Urology TimesCategories: Latest Headlines, UrologyTweet-
Dr. Siddiqui discusses recent and projected developments in bladder cancer https://t.co/P5uuWvj9L3 #urology #urologist #bladdercancer @MMSiddiquiMD @UMMC
-
-
Mashup Score: 2
evidence gaps to guide future research on the use of active surveillance to monitor low-risk prostate cancers, Overtreatment of prostate cancer has become a significant issue in recent years, PCORI Engagement Awards.
Source: www.urotoday.comCategories: Latest Headlines, UrologyTweet-
Researchers at the @UMmedschool awarded funding to lead national discussion on #ActiveSurveillance for men with low-risk #ProstateCancer. #ReadNow details on UroToday > https://t.co/CUwNgxIsww @PCORI @MMSiddiquiMD https://t.co/TfoyeZPXu5
-
-
Mashup Score: 0SUO 2020: Use of Biomarkers to Select Patients for Active Surveillance and Focal Ablation - 4 year(s) ago
SUO 2020 role for biomarkers in the selection of patients for focal therapy, Role of biomarkers in prostate cancer, prostate health index biomarker, ProtecT trial, OncotypeDX, SelectMDX, genomic prostate score.
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet-
Use of #Biomarkers to select patients for #ActiveSurveillance and focal ablation. Presented by @MMSiddiquiMD @MarylandUrology. #SUO20 written coverage by @GoldbergHanan @UrologyUpstate on UroToday > https://t.co/mwaiFqfqp1 @UroOnc @SUO_YUO https://t.co/uDDVpy5SQI
-
Do you think PSA density is useful before fusion biopsies ? Find out more on https://t.co/TJ2yDJM7rw #pcsm #psa #fusionbx @MMSiddiquiMD https://t.co/4CLxhmBMOK